Model
Edge
Relmada Therapeutics, Inc.
RLMD
Filing Type
10-Q
Filing Date
5/11/2025
Updated
5/12/25, 2:06 PM
Filing
10-Q
Earnings Release
Exhibits
10-Q
Q1
EX-10.2
EXCLUSIVE LICENSE AGREEMENT BETWEEN TRIGONE PHARMA, LTD., AND RELMADA THERAPEUTICS, INC., DATED MARCH 24, 2025
EX-31.1
CERTIFICATION
EX-31.2
CERTIFICATION
EX-32.1
CERTIFICATION
EX-32.2
CERTIFICATION